Our mission


Placing our clients (biotech, pharmaceutical companies and academic organizations) at the core of everything we do is our first priority.

We assist them with customized services all along the development of their product, from the proof of concept (POC) through to market launch.

We provide a continuum of solutions adapted to their specific needs during the different stages of the product development.

AAV, Lentivirus, Plasmid, CRISPR, CarT Cells

Our 4 domains of activities

Preclinical development – Safety and toxicology testing on samples

Quality Control testing – Product characterization

Clinical Development – Follow-up of subjects

Regulatory Affairs – Consulting and administration support



We specialize in the evaluation of cellular and gene therapy products and also other types of innovative products such as bacteria or monoclonal antibodies.

Our core offering is based on expertise in complementary scientific fields: molecular biology, immunology, virology and cell culture.

We advise and assist our clients in fulfilling their testing needs including the development of techniques that address challenges encountered during product development:


Development and validation of specific assays and analytical methods

Samples analysis


Our clients benefit from our strong Quality Assurance policy. When required, studies are performed in compliance with Good Laboratory Practices (GLP).